Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


18.06.2018

2 Ann Hematol
1 Biochem Biophys Res Commun
3 Blood
4 Bone Marrow Transplant
1 Eur J Haematol
2 J Pediatr Hematol Oncol
1 Leuk Lymphoma
1 Leuk Res
6 Leukemia
1 Oncogene
2 PLoS One
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Hematol

  1. MEGIAS-VERICAT JE, Martinez-Cuadron D, Sanz MA, Montesinos P, et al
    Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review.
    Ann Hematol. 2018;97:1115-1153.
    PubMed     Text format     Abstract available

  2. VANDER MEEREN S, Heyrman B, Renmans W, Bakkus M, et al
    Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Ann Hematol. 2018;97:1219-1227.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. XIA L, Wu L, Bao J, Li Q, et al
    Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/beta-catenin pathway.
    Biochem Biophys Res Commun. 2018 Jun 11. pii: S0006-291X(18)31357.
    PubMed     Text format     Abstract available


    Blood

  4. O'DWYER K, Freyer DR, Horan JT
    Treatment strategies for adolescent and young adult patients with acute myeloid leukemia.
    Blood. 2018 Jun 12. pii: blood-2017-12-778472. doi: 10.1182/blood-2017-12-778472
    PubMed     Text format     Abstract available

  5. BOISSEL N, Baruchel A
    Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?
    Blood. 2018 Jun 12. pii: blood-2018-02-778530. doi: 10.1182/blood-2018-02-778530
    PubMed     Text format     Abstract available

  6. ROBERTS KG, Janke LJ, Zhao Y, Seth A, et al
    ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.
    Blood. 2018 Jun 7. pii: blood-2018-05-849554. doi: 10.1182/blood-2018-05-849554.
    PubMed     Text format    


    Bone Marrow Transplant

  7. BONDA A, Punatar S, Gokarn A, Mohite A, et al
    Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia-a worthwhile strategy?
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0222.
    PubMed     Text format    

  8. FUJI S, Inoue Y, Utsunomiya A, Moriuchi Y, et al
    Impact of pretransplant central nervous system invasion in patients with aggressive adult T-cell leukemia lymphoma.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0248.
    PubMed     Text format    

  9. HOCHBERG J, Zahler S, Geyer MB, Chen N, et al
    The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuke
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0247.
    PubMed     Text format     Abstract available

  10. GABELLI M, Zecca M, Messina C, Carraro E, et al
    Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0259.
    PubMed     Text format     Abstract available


    Eur J Haematol

  11. LATAGLIATA R, Breccia M, Carmosino I, Cesini L, et al
    Clinical Results According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: the Younger, the Later, the Worse?
    Eur J Haematol. 2018 Jun 13. doi: 10.1111/ejh.13110.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  12. KIM BK, Hong KT, Kang HJ, An HY, et al
    Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
    J Pediatr Hematol Oncol. 2018 Jun 8. doi: 10.1097/MPH.0000000000001237.
    PubMed     Text format     Abstract available

  13. RAE C, Furlong W, Feeny D, Couchman R, et al
    Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
    J Pediatr Hematol Oncol. 2018 Jun 12. doi: 10.1097/MPH.0000000000001235.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  14. BERTOLI S, Tavitian S, Berard E, Gadaud N, et al
    Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies.
    Leuk Lymphoma. 2018 Jun 12:1-4. doi: 10.1080/10428194.2018.1464156.
    PubMed     Text format    


    Leuk Res

  15. DAS S, Dielschneider R, Chanas-LaRue A, Johnston JB, et al
    Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells.
    Leuk Res. 2018;70:79-86.
    PubMed     Text format     Abstract available


    Leukemia

  16. BARGHOUT SH, Patel PS, Wang X, Xu GW, et al
    Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
    Leukemia. 2018 Jun 8. pii: 10.1038/s41375-018-0167.
    PubMed     Text format     Abstract available

  17. TIMILSHINA N, Breunis H, Tomlinson GA, Brandwein JM, et al
    Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy.
    Leukemia. 2018 Jun 8. pii: 10.1038/s41375-018-0162.
    PubMed     Text format     Abstract available

  18. TASIAN SK, Casas JA, Posocco D, Gandre-Babbe S, et al
    Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells.
    Leukemia. 2018 Jun 8. pii: 10.1038/s41375-018-0169.
    PubMed     Text format     Abstract available

  19. BOUDREAUX SP, Duren RP, Call SG, Nguyen L, et al
    Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.
    Leukemia. 2018 Jun 8. pii: 10.1038/s41375-018-0174.
    PubMed     Text format     Abstract available

  20. BODDU P, Gurguis C, Sanford D, Cortes J, et al
    Response kinetics and factors predicting survival in core-binding factor leukemia.
    Leukemia. 2018 Jun 8. pii: 10.1038/s41375-018-0158.
    PubMed     Text format    

  21. ERNST T, Busch M, Rinke J, Ernst J, et al
    Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.
    Leukemia. 2018 Jun 13. pii: 10.1038/s41375-018-0157.
    PubMed     Text format    


    Oncogene

  22. ZHANG Y, Zhou X, Li Y, Xu Y, et al
    Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0333.
    PubMed     Text format     Abstract available


    PLoS One

  23. ALI SA, Malakar D, Kaushik JK, Mohanty AK, et al
    Recombinant purified buffalo leukemia inhibitory factor plays an inhibitory role in cell growth.
    PLoS One. 2018;13:e0198523.
    PubMed     Text format     Abstract available

  24. LIEN MY, Chou CH, Lin CC, Bai LY, et al
    Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    PLoS One. 2018;13:e0197851.
    PubMed     Text format     Abstract available


    Virology

  25. REN C, Yu M, Zhang Y, Fan M, et al
    Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1B.
    Virology. 2018;519:121-130.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: